[REGN] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -58.12%
YoY- -64.98%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 2,857,200 5,138,500 1,952,000 1,933,700 1,608,022 1,470,116 1,212,629 15.34%
PBT 963,200 3,752,800 918,900 224,700 656,074 525,850 292,256 21.97%
Tax 111,100 653,900 21,600 31,600 104,662 138,106 96,038 2.45%
NP 852,100 3,098,900 897,300 193,100 551,412 387,744 196,218 27.71%
Tax Rate -11.53% -17.42% -2.35% -14.06% -15.95% -26.26% -32.86% -
Total Cost 2,005,100 2,039,600 1,054,700 1,740,600 1,056,610 1,082,372 1,016,411 11.98%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 29.82 60.31 45.97 9.99 34.29 26.38 16.18 10.72%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS 7.47 29.51 8.19 1.77 5.12 3.66 1.88 25.83%
EPS Diluted 7.47 27.97 7.61 1.68 4.82 3.34 1.69 28.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.